The Health Sciences Learning Center opened near the University of Wisconsin Hospital
On May 7, 2004, the Health Sciences Learning Center opened near the University of Wisconsin Hospital and Clinics….
NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccine
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…
DNA Day commemorates the successful completion of the Human Genome Project and discovery of DNA’s double helix
On April 25 known as DNA Day, is a day that commemorates the successful completion of the Human…
The Virginia Bioinformatics Institute opened Bioinformatics Facility I
On Apr. 24, 2004, the Virginia Bioinformatics Institute, opened its new 59,000-square-foot Bioinformatics Facility I The mission of…
Eli Lilly and Company launched Symbyax in the U.S.
On Apr. 19, 2004, Eli Lilly and Company launched Symbyax in the U.S., the first and only Food…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
The Priestley Medal was awarded to George A Olah
On Apr. 5 2004, The Priestley Medal was awarded to George A. Olah by the American Chemical Society…
Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed
On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…
Biotechnology | Diagnostics | FDA | Life Science News | NIH | Oncology
The FDA and NCI announced they will share knowledge and resources to facilitate development of new cancer drugs
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute for Brain Science at Columbia University Medical Center
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
The Kavli Foundation established the Kavli Institute for Brain and Mind at the University of California, San Diego
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
FDA banned dietary supplements containing ephedrine alkaloids
On Feb. 9, 2004, deeming such products to present an unreasonable risk of harm, the FDA banned dietary…
The monoclonal antibody cetuximab (Erbitux) was approved by the FDA for the treatment of metastatic colorectal cancer
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Ophthalmogy | Therapeutics
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
The International Tomato Genome Sequencing Project was launched
On Jan. 28, 2004, the International Tomato Genome Sequencing Project was begun by an international consortium including participants…
The U.S. Congress enacted the Sun Grant Research Initiative Act
On Jan. 23, 2004, the U.S. Congress enacted the Sun Grant Research Initiative Act. The Sun Grant Research…
The FDA approved oxaliplatin (Eloxatin) for use in the treatment of advanced colorectal cancer
On Jan. 9, 2004, the FDA announced the approval of Eloxatin (oxaliplatin) injection for initial treatment of advanced…
BioKansas was founded
In 2004, BioKansas was founded by the Kansas City Area Life Sciences Institute and the State of Kansas,…
Siemens introduced Acuris, the first hearing instrument featuring a wireless system, e2e wireless, small enough to fit in CICs
In 2004, Siemens, now Sivantos, introduced Acuris, the first hearing instrument featuring a wireless system, e2e wireless, small…
Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics | Vaccine
The University of Georgia Cancer Center was established
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
Rubella was declared eliminated in the U.S.
In 2004, Rubella, also known as German measles, was declared eliminated in the U.S. Before the rubella vaccination…
The Delaware BioScience Association was founded
In 2004, representatives from a cross-section of bioscience enterprises met under the direction of Governor Ruth Ann Minner…
Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
Biotechnology | Diagnostics | FDA | Life Science News | NIH | Oncology | Therapeutics
The National Cancer Institute collaborated with the Department of Health and Human Services to establish National Network of Tobacco Cessation Quitlines
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five years of tamoxifen therapy
In 2004, Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five…
The Emergency Use Authorization program was established
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New Medical Products”
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…